Clinical Trial of YYD302 (Phase3) for Treatment of Osteoarthritis of the Knee
Status:
Completed
Trial end date:
2019-10-04
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, active-controlled, multi-center, phase 3 study to
evaluate the safety and efficacy of intraarticular hyaluronic acid(YYD302) for osteoarthritis
of the knee after 12 weeks of treatment and retreatment